The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Prepulse Inhibition Deficits and Perseverative Motor Patterns in Dopamine Transporter Knock-Out Mice: Differential Effects of D1 and D2 Receptor Antagonists
Open accessAbstract
Dopamine is known to regulate several behavioral phenomena, including sensorimotor gating and aspects of motor activity. The roles of dopamine D1 and D2 receptors in these behaviors have been documented in the rat literature, but few reports exist on their role in mice. We used dopamine transporter (DAT) (−/−) mice to examine the behavioral consequences of a chronically hyperdopaminergic state, challenging them with the preferential dopamine D2 receptor antagonist raclopride and D1 receptor antagonist SCH23390. At baseline, DAT (−/−) mice exhibited deficient sensorimotor gating as measured by prepulse inhibition (PPI) of the startle response, exhibited nonfocal perseverative patterns of locomotion, and were hyperactive in a novel environment. Pretreatment with raclopride significantly increased PPI in the DAT (−/−) mice, whereas SCH23390 had no significant effect. Blockade of D2 receptors did not affect the predominantly straight patterns of motor behavior produced by the DAT (−/−) mice, but antagonism of D1 receptors significantly attenuated the perseverative patterns, producing more of a meandering behavior seen in the DAT (+/+) control mice. Both D1 and D2 receptor antagonists decreased the hyperactivity seen in the DAT (−/−) mice. These findings support the role of the D2, but not the D1, receptor in the modulation of PPI in mice. Furthermore, D1 receptor activation appears to be the critical substrate for the expression of perseverative patterns of motor behavior, whereas both D1 and D2 receptors appear to regulate the amount of motor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The DAT knockout mice phenotypes resemble amphetamine-like effects, and both hyperlocomotion and PPI deficits can be reversed with either D1 or D2 receptor antagonists [376], the atypical antipsychotics clozapine and quetiapine [377], various antidepressant drugs, and monoamine transporter inhibitors [378].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [376]
In the citing paper
“Mice lacking the DAT gene display markedly increased levels of DA in the mesolimbic system and striatum [373], that results in hyperlocomoter behaviors [373,374] and also deficits in PPI [375,376].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [376]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Self-citationGenetics of Mouse Behavior: Interactions with Laboratory Environment
Crabbe, J. C., Wahlsten, D., & Dudek, B. C. (1999) · Science · doi:10.1126/science.284.5420.1670 · Cited by 1,666
The more or less startling effects of weak prestimulation
Graham, F. K. (1975) · Psychophysiology · doi:10.1111/j.1469-8986.1975.tb01284.x · Cited by 1,119
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Hoffman, H. S., & Ison, J. R. (1980) · Psychological Review · doi:10.1037/0033-295x.87.2.175 · Cited by 780
Profound neuronal plasticity in response to inactivation of the dopamine transporter
Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.4029 · Cited by 712
Self-citationDopaminergic stimulation disrupts sensorimotor gating in the rat
Mansbach, R. S., Geyer, M. A., & BRAFF, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00212846 · Cited by 606
Self-citationSensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results
Castellanos, F. X., Fine, E. J., Kaysen, D. L., Marsh, W., Rapoport, J. L., & Hallett, M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00101-8 · Cited by 395
A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder
Swerdlow, N. R., Benbow, C. H., Zisook, S., Geyer, M. A., & BRAFF, D. L. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90300-3 · Cited by 351
Self-citationCadenhead, K. S., Geyer, M. A., & BRAFF, D. L. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1862 · Cited by 307
Self-citation
Research works printed but not linked: 2
- Paulus, 1997, Dopamine transporter (DAT) (+/−) and (−/−) mice exhibit graded changes in geometric patterns of locomotor behavior., Soc Neurosci Abstr, 23, 722.1
- Ralph, 1997, Prepulse inhibition deficits in dopamine transporter (DAT) knockout mice., Soc Neurosci Abstr, 23, 722.3
Cited by
Sorted by citations
Items 101–200 of 269
The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms
Landgraf, D., Joiner, W. J., McCarthy, M. J., Kießling, S., Barandas, R., Young, J. W., Cermakian, N., & Welsh, D. K. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.047 · Cited by 44
Pervolaraki, E., Hall, S. P., Foresteire, D., Saito, T., Saido, T. C., Whittington, M. A., Lever, C., & Dachtler, J. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.040550 · Cited by 42
MDMA ?ecstasy? alters hyperactive and perseverative behaviors in dopamine transporter knockout mice
Powell, S. B., Masten, V. L., Paulus, M. P., Gainetdinov, R. R., Caron, M. G., & Geyer, M. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1765-7 · Cited by 42
Self-citationFunctional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice
Weiss, S., Tzavara, E. T., Davis, R. J., Nomikos, G. G., McIntosh, J. M., Giros, B., & Martres, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.002 · Cited by 44
Godar, S. C., Bortolato, M., Castelli, M. P., Casti, A., Casu, A., Chen, K. Y., Ennas, M. G., Tambaro, S., & Shih, J. C. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.04.014 · Cited by 44
Frau, R., Pillolla, G., Bini, V., Tambaro, S., Devoto, P., & Bortolato, M. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.07.014 · Cited by 43
Medvedev, I. O., Gainetdinov, R. R., Sotnikova, T. D., Bohn, L., Caron, M. G., & Dykstra, L. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2173-y · Cited by 42
Self-citationVisualization of the Cocaine-Sensitive Dopamine Transporter with Ligand-Conjugated Quantum Dots
Kovtun, O., Tomlinson, I. D., Sakrikar, D. S., Chang, J. C., Blakely, R., & Rosenthal, S. J. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200032r · Cited by 41
Kovtun, O., Sakrikar, D. S., Tomlinson, I. D., Chang, J. C., Arzeta-Ferrer, X., Blakely, R., & Rosenthal, S. J. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500202c · Cited by 41
Cognitive deficits caused by a disease-mutation in the α3 Na+/K+-ATPase isoform
Holm, T. H., Isaksen, T. J., Glerup, S., Heuck, A., Bøttger, P., Füchtbauer, E., Nedergaard, S., Nyengaard, J. R., Andreasen, M. M., Nissen, P., et al. (2016) · Scientific Reports · doi:10.1038/srep31972 · Cited by 39
The involvement of DARPP-32 in the pathophysiology of schizophrenia
Wang, H., Farhan, M., Xu, J., Lazarovici, P., & Zheng, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17339 · Cited by 38
Alteration of methamphetamine-induced striatal dopamine release in mint-1 knockout mice
Mori, A., Okuyama, K., Horie, M., Taniguchi, Y., Wadatsu, T., Nishino, N., Shimada, Y., Miyazawa, N., Takeda, S., Niimi, M., et al. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00041-x · Cited by 39
Disrupted sensory gating in pathological gambling
Stojanov, W., Karayanidis, F., Johnston, P., Bailey, A., Carr, V. J., & Schall, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01745-6 · Cited by 39
The projection-specific signals that establish functionally segregated dopaminergic synapses
Terauchi, A., Yee, P., Johnson‐Venkatesh, E., Seiglie, M. P., Kim, L., Pitino, J. C., Kritzer, E., Zhang, Q., Zhou, J., Li, Y., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.023 · Cited by 38
Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs
Sora, I., Li, B., Igari, M., Hall, F. S., & Ikeda, K. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05276.x · Cited by 38
Bipolar Disorder: Its Etiology and How to Model in Rodents
Freund, N., & Juckel, G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_4 · Cited by 38
Campbell, D. L. M., Dallaire, J. A., & Mason, G. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.004 · Cited by 39
Pathak, G., Ibrahim, B. A., McCarthy, S. A., Baker, K. B., & Kelly, M. P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.026 · Cited by 35
Behavioral and Molecular Biomarkers in Translational Animal Models for Neuropsychiatric Disorders
Sarnyai, Z., Alsaif, M., Bahn, S., Ernst, A., Guest, P. C., Hradetzky, E., Kluge, W. F., Stelzhammer, V., & Wesseling, H. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00008-0 · Cited by 35
van Enkhuizen, J., Geyer, M. A., Minassian, A., Perry, W., Henry, B. L., & Young, J. W. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.008 · Cited by 32
Self-citationADHD and the Dopamine Transporter: Are There Reasons to Pay Attention?
Mazei‐Robison, M. S., & Blakely, R. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_17 · Cited by 34
Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and ‘Schizophrenia-Like Behaviors’ in Mice
Vitucci, D., Giorgio, A. D., Napolitano, F., Pelosi, B., Blasi, G., Errico, F., Attrotto, M. T., Gelao, B., Fazio, L., Taurisano, P., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.228 · Cited by 33
Zuloaga, D. G., Jordan, C. L., & Breedlove, S. M. (2011) · Endocrinology · doi:10.1210/en.2010-1016 · Cited by 33
Berlanga, M. L., Price, D. L., Phung, B. S., Giuly, R., Terada, M., Yamada, N., Cyr, M., Caron, M. G., Laakso, A., Martone, M. E., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.044 · Cited by 34
Self-citationAn updated review on animal models to study attention-deficit hyperactivity disorder
Kim, D., Yadav, D., & Song, M. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02893-0 · Cited by 38
de la Peña, J. B., Peña, I. J. D., Custodio, R. J. P., Botanas, C. J., Kim, H. J., & Cheong, J. H. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0608-1 · Cited by 38
Tan, S., Hermann, B., & Borrelli, E. (2003) · International review of neurobiology · doi:10.1016/s0074-7742(03)54005-3 · Cited by 32
Fazio, L., Blasi, G., Taurisano, P., Papazacharias, A., Romano, R., Gelao, B., Ursini, G., Quarto, T., Bianco, L. L., Giorgio, A. D., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.11.034 · Cited by 32
Burhans, M. S., Dailey, C., Wiesinger, J. A., Murray‐Kolb, L. E., Jones, B. C., & Beard, J. L. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.02.014 · Cited by 31
Del’Guidice, T., Lemasson, M., Etiévant, A., Manta, S., Magno, L. A. V., Escoffier, G., Roman, F. S., & Beaulieu, J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3212-8 · Cited by 30
Ison, J. R., & Allen, P. D. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.014 · Cited by 28
Chronic Toxoplasma gondii in Nurr1-Null Heterozygous Mice Exacerbates Elevated Open Field Activity
Eells, J. B., Varela‐Stokes, A. S., Guo‐Ross, S. X., Kummari, E., Smith, H. M., Cox, E., & Lindsay, D. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119280 · Cited by 28
Mouse Cognition-Related Behavior in the Open-Field: Emergence of Places of Attraction
Dvorkin‐Gheva, A., Benjamini, Y., & Golani, I. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000027 · Cited by 28
Developing New Drugs for Schizophrenia: From Animals to the Clinic
Jones, D. N. C., Gartlon, J. E., Minassian, A., Perry, W., & Geyer, M. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00008-4 · Cited by 30
Self-citationHitzemann, R., Malmanger, B., Belknap, J. K., Darakjian, P., & McWeeney, S. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.04.004 · Cited by 27
Thal, L. B., Tomlinson, I. D., Quinlan, M. A., Kovtun, O., Blakely, R., & Rosenthal, S. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00350 · Cited by 27
A protein phosphatase 2A deficit in the hippocampal CA1 area impairs memory extinction
Wang, J., Xie, R., Kou, X., Liu, Y., Cui, Q., Liu, R., You, W., Gao, J., & Gao, X. (2019) · Molecular Brain · doi:10.1186/s13041-019-0469-9 · Cited by 27
Constitutive Hyperdopaminergia is Functionally Associated with Reduced Behavioral Lateralization
Morice, É., Denis, C., Macario, A., Bruno Giros, A., & Nosten‐Bertrand, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300570 · Cited by 27
Morello, F., Võikar, V., Parkkinen, P., Panhelainen, A. E., Rosenholm, M., Makkonen, A., Rantamäki, T., Piepponen, P. T., Aitta‐aho, T., & Partanen, J. M. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01033-8 · Cited by 25
Hall, F. S., Sora, I., Hen, R., & Uhl, G. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115009 · Cited by 28
Khoja, S., Asatryan, L., Jakowec, M. W., & Davies, D. L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00331 · Cited by 28
Zhang, M., Ballard, M. E., Kohlhaas, K. L., Browman, K. E., Jongen-Rêlo, A.-L., Unger, L., Fox, G. B., Groß, G., Decker, M. W., Drescher, K. U., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300985 · Cited by 26
Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience
Savchenko, A. A., Targa, G., Fesenko, Z. S., Leo, D., Gainetdinov, R. R., & Sukhanov, I. (2023) · Biomolecules · doi:10.3390/biom13050806 · Cited by 31
Tejeda, H. A., Chefer, V. I., Zapata, A. G., & Shippenberg, T. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1799-6 · Cited by 25
Arime, Y., Kasahara, Y., Hall, F. S., Uhl, G. R., & Sora, I. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.114 · Cited by 26
Strengths and limitations of genetic models of ADHD
Gainetdinov, R. R. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0021-3 · Cited by 24
Young, J. W., Winstanley, C. A., Brady, A. M., & Hall, F. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.029 · Cited by 28
Zoetmulder, M., Biernat, H. B., Nikolic, M., Korbo, L., Friberg, L., & Jennum, P. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130307 · Cited by 24
Zhang, Z.-J., Jiang, X., Zhang, S. E., Hough, C. J., Li, H., Chen, J., & Zhen, X.-C. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.001 · Cited by 23
Niculescu, A. B., & Kelsoe, J. R. (2002) · CNS Spectrums · doi:10.1017/s1092852900017582 · Cited by 21
Sotoyama, H., Namba, H., Tohmi, M., & Nawa, H. (2023) · Biomolecules · doi:10.3390/biom13020372 · Cited by 24
Bellesi, M., & Conti, F. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.225 · Cited by 22
Kucinski, A. J., Syposs, C., Wersinger, S. R., Bencherif, M., Stachowiak, M. K., & Stachowiak, E. K. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.01.005 · Cited by 22
Tammimäki, A., Forsberg, M., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00267.x · Cited by 23
Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating
Vinkers, C. H., Risbrough, V. B., Geyer, M. A., Caldwell, S., Low, M. J., & Hauger, R. L. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.01.018 · Cited by 21
Self-citationOkada, H., Inoue, T., Hashimoto, K., Suzuki, H., & Matsushita, S. (2009) · American Journal of Nephrology · doi:10.1159/000225902 · Cited by 21
Genetics of Equine Behavioral Traits
Wickens, C. L., & Brooks, S. A. (2020) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2020.03.014 · Cited by 20
Psychotropic and Neurotropic Activity
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_6 · Cited by 22
Allopregnanolone: The missing link to explain the effects of stress on tic exacerbation?
Bortolato, M., Coffey, B. J., Gabbay, V., & Scheggi, S. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13022 · Cited by 20
Zoetmulder, M., Biernat, H. B., Nikolic, M., Korbo, L., & Jennum, P. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.11.018 · Cited by 19
Vuillermot, S., Feldon, J., & Meyer, U. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.07.008 · Cited by 18
Osuch, E. A., Ursano, R. J., He, L., Webster, M. J., Hough, C., Fullerton, C. S., & Leskin, G. A. (2004) · Psychiatry · doi:10.1521/psyc.67.4.353.56565 · Cited by 18
Using rodents to model schizophrenia and substance use comorbidity
Ng, E., McGirr, A., Wong, A. H. C., & Roder, J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.025 · Cited by 19
Contribution of nonprimate animal models in understanding the etiology of schizophrenia
Lazar, N. L., Neufeld, R. W. J., & Cain, D. P. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100054 · Cited by 20
Mielnik, C. A., Sugamori, K. S., Finlay, D. B., Thorpe, H. H. A., Schapira, M., Sivananthan, N., Li, C. K., Lam, V. M., Harrington, S., Abdelrahman, M. H., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00876-5 · Cited by 17
Uchiumi, O., Kasahara, Y., Fukui, A., Hall, F. S., Uhl, G. R., & Sora, I. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.016 · Cited by 17
Gainetdinov, R. R., & Caron, M. G. (2002) · Cited by 17
Self-citationLloyd, J. T., Yee, A. G., Kalligappa, P., Jabed, A., Cheung, P. Y., Todd, K. L., Karunasinghe, R. N., Vlajkovic, S. M., Freestone, P. S., & Lipski, J. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2022.03.019 · Cited by 16
Itohara, S., Kobayashi, Y., & Nakashiba, T. (2014) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2014.09.002 · Cited by 16
Lyon, K. A., Rood, B. D., Wu, L., Senft, R. A., Goodrich, L. V., & Dymecki, S. M. (2020) · eNeuro · doi:10.1523/eneuro.0202-20.2020 · Cited by 16
Motor deficits in fibroblast growth factor receptor-3 null mutant mice
McDonald, M. P., Miller, K., Li, C., Deng, C., & Crawley, J. N. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00009 · Cited by 16
Ptukha, M. A., Fesenko, Z. S., Belskaya, A. D., Gromova, A. A., Pelevin, A., Kurzina, N. P., Gainetdinov, R. R., & Volnova, A. B. (2022) · Biomolecules · doi:10.3390/biom12101484 · Cited by 15
Ye, J., Ji, F., Jiang, D., Lin, X., Chen, G., Zhang, W., Shan, P., Zhang, L., & Zhuo, C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00355 · Cited by 16
Rats Lacking the Dopamine Transporter Display Inflexibility in Innate and Learned Behavior
Belskaya, A. D., Kurzina, N. P., Savchenko, A. A., Sukhanov, I., Gromova, A. A., Gainetdinov, R. R., & Volnova, A. B. (2024) · Biomedicines · doi:10.3390/biomedicines12061270 · Cited by 15
TAAR5 receptor agonist affects sensory gating in rats
Aa, A., Es, D., Volnova, A. B., Knyazeva, V. M., Gerasimov, A. S., & Gainetdinov, R. R. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.053 · Cited by 14
Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models
Nespoli, E., Rizzo, F. R., Boeckers, T. M., Hengerer, B., & Ludolph, A. G. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00133 · Cited by 16
The chakragati mouse: A mouse model for rapid in vivo screening of antipsychotic drug candidates
Dawe, G. S., & Ratty, A. K. (2007) · Biotechnology Journal · doi:10.1002/biot.200700145 · Cited by 14
Gao, N., Liu, Z., Wang, H., Shen, C., Dong, Z., Cui, W., Xiong, W., & Mei, L. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0247-23.2023 · Cited by 14
Frau, R., & Melis, M. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13240 · Cited by 13
Volnova, A. B., Kurzina, N. P., Belskaya, A. D., Gromova, A. A., Pelevin, A., Ptukha, M. A., Fesenko, Z. S., Ignashchenkova, A., & Gainetdinov, R. R. (2023) · Biomedicines · doi:10.3390/biomedicines11010222 · Cited by 13
Bahí, A., & Dreyer, J. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5144-9 · Cited by 12
Regulation of Monoamine Transporters: Regulated Phosphorylation, Dephosphorylation, and Trafficking
Ramamoorthy, S. (2003) · Humana Press eBooks · doi:10.1385/1-59259-158-2:001 · Cited by 12
Sasaki, A., Wetsel, W. C., Rodriguiz, R. M., & Meck, W. H. (2001) · International Journal of Comparative Psychology · doi:10.46867/c4rc85 · Cited by 11
Chapter V Motor function(s) of the nigrostriatal dopamine system: Studies of lesions and behavior
Dunnett, S. B. (2005) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(05)80009-0 · Cited by 10
The Evolutionary Origins of Cognitive Control
Hills, T. T. (2011) · Topics in Cognitive Science · doi:10.1111/j.1756-8765.2011.01135.x · Cited by 10
Findlay, G. S., Harris, R. A., & Blednov, Y. A. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.08.011 · Cited by 9
Østerbøg, T. B., On, D. M., Oliveras, I., Río-Álamos, C., Sánchez-González, A., Tapias-Espinosa, C., Tobeña, A., González‐Maeso, J., Fernández‐Teruel, A., & Aznar, S. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01829-w · Cited by 12
Ohara, A., Kasahara, Y., Yamamoto, H., Hata, H., Kobayashi, H., Numachi, Y., Miyoshi, I., Hall, F. S., Uhl, G. R., Ikeda, K., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.014 · Cited by 9
The effects of DAT1 genotype on fMRI activation in an emotional go/no-go task
Brown, B. K., Murrell, J. R., Karne, H. S., & Anand, A. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9516-7 · Cited by 11
Mandell, A. J., Selz, K. A., Owens, M. J., Kinkead, B. L., Shlesinger, M. F., Gutman, D. A., & Arguragi, V. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300134 · Cited by 9
Timing behavior in genetic murine models of neurological and psychiatric diseases
Karson, A., & Balcı, F. (2021) · Experimental Brain Research · doi:10.1007/s00221-020-06021-4 · Cited by 7
The role of dopamine D1 receptors in MDMA-induced memory impairments
Squire, H., Youn, J., Ellenbroek, B. A., & Harper, D. N. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107322 · Cited by 8
Broderick, P. A., & Rosenbaum, T. (2013) · Brain Sciences · doi:10.3390/brainsci3020504 · Cited by 7
Brandner, D. D., Retzlaff, C. L., Kocharian, A., Stieve, B. J., Mashal, M. A., Mermelstein, P. G., & Rothwell, P. E. (2022) · Addiction Biology · doi:10.1111/adb.13247 · Cited by 6
Mice in Ecstasy: Advanced Animal Models in the Study of MDMA
Stove, C. P., Letter, E. A. D., Piette, M. H. A., & Lambert, W. E. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110791591508 · Cited by 6
Stanford, S. C. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_342 · Cited by 7
Experimental autoimmune encephalomyelitis: An animal model for multiple sclerosis
Gijbels, K., Engelborghs, S., & Deyn, P. P. D. (2000) · Neuroscience Research Communications · doi:10.1002/1520-6769(200005/06)26:3 · Cited by 9
Isles, A. R., McNamara, G. I., & John, R. M. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.06.008 · Cited by 5
Genetic advances and translational phenotypes in rodent models for Tourette disorder
Kowalski, T. F., Wang, R., & Tischfield, M. A. (2025) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102967 · Cited by 5
Genetic and Environmental Influences on Criminal Behavior
Rae, M. N. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 5
Metadata
- Authors
- Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., & Geyer, M. A.
- Affiliations
- University of California San Diego (US)
- University of Milan (IT)
- Howard Hughes Medical Institute (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2001-01-01
- Volume
- 21
- Issue
- 1
- Pages
- 305-313
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6762423
- OpenAlex
- W2133067994
- Cited by
- 271
- References
- 31
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 12 · 2022: 9 · 2021: 4 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 8 · 2016: 13 · 2015: 12 · 2014: 15 · 2013: 12 · 2012: 11
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- U.S. Department of Veterans Affairs
- National Institutes of Health (5r01da011277-03)
- National Institute of Mental Health (F31-MH-12806, MH42228, R37MH042228, R01MH042228, R01MH061326)
- National Institute on Drug Abuse (DA 02925, R01DA002925, DA11277)
- NIH Clinical Center
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- prepulse inhibition, sensorimotor gating, dopamine transporter knockout mice, dopamine D1 receptor, dopamine D2 receptor, dopamine D1 receptor antagonist, dopamine D2 receptor antagonists, raclopride, SCH 23390, locomotor hyperactivity, hyperdopaminergic state
- MeSH terms
- Animals, Behavior, Animal, Benzazepines, Carrier Proteins, Female, Heterozygote, Homozygote, Hyperkinesis, Injections, Intraperitoneal, Injections, Subcutaneous, Male, Membrane Glycoproteins, Motor Activity, Movement Disorders, Nerve Tissue Proteins, Neural Inhibition, Sex Factors, Reflex, Startle, Receptors, Dopamine D1, Receptors, Dopamine D2, Mice, Knockout, Dopamine Antagonists, Raclopride, Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins, Mice, Dopamine D2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review